The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Dr Stefano Giulieri

Dr Stefano Giulieri

+61 3 8344 5701 |

Clinician Researcher and Infectious Diseases Physician
Antimicrobial Resistance, Bacterial and Parasitic Infections, Computational Science and Genomics, Clinical and Health Systems Research
Computational Science and Genomics, Clinical and health systems research
The University of Melbourne, Department of Microbiology and Immunology (DMI) , Department of Medicine (Austin Health), Victorian Infectious Diseases Service (VIDS)
Lab Group(s):
Howden Group

Dr Stefano Giulieri is a clinician researcher with a special interest in staphylococcal genomics and orthopaedic infections. He is passionate about using evolutionary biology, statistical genomics and machine learning approaches to answer clinical questions in infectious diseases. He is particularly interested in how bacteria like the hospital superbug Staphylococcus aureus, evolve within patients during severe infections to evade both antibiotics and immune responses. He is an Infectious Diseases Physician at the Royal Melbourne Hospital where he has a clinic specialised in orthopaedics infections. Before moving to Melbourne, he was the Head of the Infectious Diseases Consultation in the Orthopaedics Department at the Lausanne University Hospital, Switzerland.

  • Key Achievements
    • Stefano was awarded his MD at the University of Basel in Switzerland and is a fellow of both the Swiss Medical Association (FMH) and the Royal Australasian College of Physicians (RACP) in Infectious Diseases. He completed his PhD in bacterial genomics at the University of Melbourne in 2022. He has been recipient of the following awards and grants:

      Melbourne Genomics Immersion Fellowship (2023)

      Swiss Society for Infectious Diseases (SSI)/SAFE-ID Award for basic research (2018)

      Travel grant of the International Symposium on Staphylococci and Staphylococcal Infections (2016)

      Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) - Program Committee Award (2012)

    Loading ORCID data…
    Research Groups
    • Howden Group

      Research from Professor Ben Howden’s group uses genomics, molecular biology, epidemiology and clinical studies to address a broad range of issues related to invasive bacterial diseases in humans, especially those caused by staphylococci, enterococci and other antimicrobial-resistant species. Additionally, working closely with scientists in the MDU PHL, they investigate the epidemiology, evolution and spread of bacterial pathogens of public health significance such as Neisseria gonorrhoea, Listeria monocytogenes, Shigella and Salmonella spp., Legionella spp., and carbapenemase-producing gram-negative bacteria.

      Lab Team

      Howden Group